Prot# 99-C-0051L: A Phase III Multi-Institutional Randomized Study of Immunization with the gp100: 209-217(210M) Peptide Followed by High Dose IL-2 vs. High Dose IL-2 Alone in Patients with Metastatic Melanoma (NCI Prot# T98-0085)

  • Kuzel, Timothy Michael (PD/PI)

Project: Research project

Project Details

StatusFinished
Effective start/end date4/30/03 → 1/1/11

Funding

  • Chiron Corporation (99-C-0051L / NCI T98-0085)